ADMA Biologics News - August 31, 2026

BlackRock's 16.5% Stake in ADMA Biologics Signals Big-Money Confidence, but Can a Plasma Drug Company Justify the Hype?

Shares of ADMA Biologics surged 9.2% to $10.20 on August 31, bucking a softer broader market, after BlackRock disclosed ownership of roughly 38.4 million...

🟢 ADMA Biologics is trading 9.21% up in pre-market after BlackRock disclosed a 16.5% stake

ADMA Biologics is trading 9.21% up in pre-market at $10.20 after BlackRock disclosed ownership of 38,355,684 shares, representing about 16.5% of the...